133 related articles for article (PubMed ID: 23867070)
1. Amoxicillin-clavulanic acid resistance in fecal Enterobacteriaceae from patients with cystic fibrosis and healthy siblings.
Duytschaever G; Huys G; Boulanger L; De Boeck K; Vandamme P
J Cyst Fibros; 2013 Dec; 12(6):780-3. PubMed ID: 23867070
[TBL] [Abstract][Full Text] [Related]
2. Antibiotic Resistance, Virulence Factors, Phenotyping, and Genotyping of Non-
Amaretti A; Righini L; Candeliere F; Musmeci E; Bonvicini F; Gentilomi GA; Rossi M; Raimondi S
Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32156029
[TBL] [Abstract][Full Text] [Related]
3. [Resistance of Escherichia coli isolated from the urinary tract to amoxicillin-clavulanic acid and other antibiotics].
Ferjani A; Marzouk M; Ben Moussa F; Boukadida J
Med Mal Infect; 2010 Mar; 40(3):161-4. PubMed ID: 19616395
[TBL] [Abstract][Full Text] [Related]
4. Impact of extensive antibiotic treatment on faecal carriage of antibiotic-resistant enterobacteria in children in a low resistance prevalence setting.
Knudsen PK; Brandtzaeg P; Høiby EA; Bohlin J; Samuelsen Ø; Steinbakk M; Abrahamsen TG; Müller F; Gammelsrud KW
PLoS One; 2017; 12(11):e0187618. PubMed ID: 29112974
[TBL] [Abstract][Full Text] [Related]
5. [Effect of BRL 25000 (clavulanic acid-amoxicillin) on bacterial flora in human feces].
Motohiro T; Tanaka K; Koga T; Shimada Y; Tomita N; Sakata Y; Fujimoto T; Nishiyama T; Kuda N; Ishimoto K
Jpn J Antibiot; 1985 Feb; 38(2):441-80. PubMed ID: 3847525
[TBL] [Abstract][Full Text] [Related]
6. Comparative in vitro activity of a pharmacokinetically enhanced oral formulation of amoxicillin/clavulanic acid (2000/125 mg twice daily) against 9172 respiratory isolates collected worldwide in 2000.
Koeth LM; Jacobs MR; Good CE; Bajaksouzian S; Windau A; Jakielaszek C; Saunders KA
Int J Infect Dis; 2004 Nov; 8(6):362-73. PubMed ID: 15494258
[TBL] [Abstract][Full Text] [Related]
7. Study of the spread of antimicrobial-resistant Enterobacteriaceae from wild mammals in the National Park of Aspromonte (Calabria, Italy).
Foti M; Siclari A; Mascetti A; Fisichella V
Environ Toxicol Pharmacol; 2018 Oct; 63():69-73. PubMed ID: 30172957
[TBL] [Abstract][Full Text] [Related]
8. Impact of oral amoxicillin and amoxicillin/clavulanic acid treatment on bacterial diversity and β-lactam resistance in the canine faecal microbiota.
Espinosa-Gongora C; Jessen LR; Kieler IN; Damborg P; Bjørnvad CR; Gudeta DD; Pires Dos Santos T; Sablier-Gallis F; Sayah-Jeanne S; Corbel T; Nevière A; Hugon P; Saint-Lu N; de Gunzburg J; Guardabassi L
J Antimicrob Chemother; 2020 Feb; 75(2):351-361. PubMed ID: 31778166
[TBL] [Abstract][Full Text] [Related]
9. [Detection of carbapenem-producing Enterobacteriaceae by MALDI-TOF MS].
Wang LJ; Fan YY; Wang M; Lu XX
Zhonghua Yi Xue Za Zhi; 2013 Jul; 93(26):2079-81. PubMed ID: 24169292
[TBL] [Abstract][Full Text] [Related]
10. Molecular epidemiology and resistance mechanisms involved in reduced susceptibility to amoxicillin/clavulanic acid in Klebsiella pneumoniae isolates from a chronic care centre.
Pérez-Moreno MO; Centelles-Serrano MJ; Cortell-Ortolá M; Fort-Gallifa I; Ruiz J; Llovet-Lombarte MI; Picó-Plana E; Jardí-Baiges AM
Int J Antimicrob Agents; 2011 May; 37(5):462-6. PubMed ID: 21316198
[TBL] [Abstract][Full Text] [Related]
11. Use of matrix assisted laser desorption ionisation-time of flight mass spectrometry in a paediatric clinical laboratory for identification of bacteria commonly isolated from cystic fibrosis patients.
Desai AP; Stanley T; Atuan M; McKey J; Lipuma JJ; Rogers B; Jerris R
J Clin Pathol; 2012 Sep; 65(9):835-8. PubMed ID: 22639406
[TBL] [Abstract][Full Text] [Related]
12. Is chloramphenicol making a comeback?
Nitzan O; Suponitzky U; Kennes Y; Chazan B; Raul R; Colodner R
Isr Med Assoc J; 2010 Jun; 12(6):371-4. PubMed ID: 20928993
[TBL] [Abstract][Full Text] [Related]
13. In vitro susceptibilities of Escherichia coli and Klebsiella spp. to ampicillin-sulbactam and amoxicillin-clavulanic acid.
Kacmaz B; Sultan N
Jpn J Infect Dis; 2007 Jul; 60(4):227-9. PubMed ID: 17642541
[TBL] [Abstract][Full Text] [Related]
14. [Effect of an amoxicillin-clavulanic acid combination on the aerobic fecal flora in children].
Borderon JC; Rastegar A; Rolland JC; Laugier J
Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):569-72. PubMed ID: 3937129
[TBL] [Abstract][Full Text] [Related]
15. Changes in fecal microbiota of healthy dogs administered amoxicillin.
Grønvold AM; L'abée-Lund TM; Sørum H; Skancke E; Yannarell AC; Mackie RI
FEMS Microbiol Ecol; 2010 Feb; 71(2):313-26. PubMed ID: 20002181
[TBL] [Abstract][Full Text] [Related]
16. Differentiation of Raoultella ornithinolytica/planticola and Klebsiella oxytoca clinical isolates by matrix-assisted laser desorption/ionization-time of flight mass spectrometry.
de Jong E; de Jong AS; Smidts-van den Berg N; Rentenaar RJ
Diagn Microbiol Infect Dis; 2013 Apr; 75(4):431-3. PubMed ID: 23375086
[TBL] [Abstract][Full Text] [Related]
17. Rapid antibiotic susceptibility testing on blood cultures using MALDI-TOF MS.
Sauget M; Bertrand X; Hocquet D
PLoS One; 2018; 13(10):e0205603. PubMed ID: 30308072
[TBL] [Abstract][Full Text] [Related]
18. Oral antibiotics for infections due to multidrug-resistant Gram-negative organisms.
Glasser JS; Markelz AE; Zera WC; Beckius ML; Mende K; Murray CK
Scand J Infect Dis; 2011 Aug; 43(8):649-51. PubMed ID: 21466257
[TBL] [Abstract][Full Text] [Related]
19. [Strain of Escherichia coli resistant to broad-spectrum cephalosporin and amoxicillin/clavulanic acid].
Martín-Pozo A; Alós JI
Rev Esp Quimioter; 2012 Sep; 25(3):222-3. PubMed ID: 22987271
[No Abstract] [Full Text] [Related]
20. Amoxicillin-Clavulanic Acid Resistance in the Genus
Mancabelli L; Mancino W; Lugli GA; Argentini C; Longhi G; Milani C; Viappiani A; Anzalone R; Bernasconi S; van Sinderen D; Ventura M; Turroni F
Appl Environ Microbiol; 2021 Mar; 87(7):. PubMed ID: 33483308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
